Literature DB >> 12919117

Complementary therapy for atopic eczema and other allergic skin diseases.

Suzan Artik1, Thomas Ruzicka.   

Abstract

Atopic eczema is one of the most common chronic inflammatory skin diseases, with a prevalence of at least 10% in children and 0.5-1% in adults. The disease shows a drastically increasing tendency. This article provides an overview of the pathophysiology, pathomechanisms, prevention, and treatment of atopic eczema. We present a therapeutic concept that integrates all aspects of the complex pathophysiology that is a prerequisite for individualized and successful treatment. This is based on intervention in the pathophysiology of atopic eczema and elimination of exogenous provocation factors. Particular attention is given to unconventional therapy options such as phytotherapy, which are attracting patients in many countries, and possible effects, side effects, and interactions with other drugs are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12919117     DOI: 10.1046/j.1529-8019.2003.01624.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  4 in total

1.  Anti-inflammatory and Anti-oxidative Effects of Korean Red Ginseng Extract in Human Keratinocytes.

Authors:  Chang-Eui Hong; Su-Yun Lyu
Journal:  Immune Netw       Date:  2011-02-28       Impact factor: 6.303

Review 2.  Complementary and alternative medicine (CAM) and atopic eczema.

Authors:  T Schäfer
Journal:  Allergol Select       Date:  2017-08-04

3.  Leukotriene receptor antagonists for eczema.

Authors:  Leila Ferguson; Masaki Futamura; Efstratios Vakirlis; Reiji Kojima; Hatoko Sasaki; Amanda Roberts; Rintaro Mori
Journal:  Cochrane Database Syst Rev       Date:  2018-10-21

4.  An educational program that contributes to improved patient and parental understanding of atopic dermatitis.

Authors:  Ji Yeon Shin; Do Won Kim; Chun Wook Park; Seong Jun Seo; Young Lip Park; Jong Rok Lee; Moon Bum Kim; Kyu Han Kim; Young Suck Ro; Sang Hyun Cho
Journal:  Ann Dermatol       Date:  2014-02-17       Impact factor: 1.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.